Dynavax Technologies reported $129.37M in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adma Biologics ADMA:US $ -13.76M 4.57M
Agenus AGEN:US $ -49.24M 1.37M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Chimerix CMRX:US $ -23.47M 1.3M
Dynavax Technologies DVAX:US $ 129.37M 96.52M
Minerva Neurosciences NERV:US $ -8.72M 1.05M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Novartis NOVN:VX SF 4129M 217M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Tg Therapeutics TGTX:US $ -40.51M 28.5M